Editorial: Complement and COVID-19 Disease

Editorial: Complement and COVID-19 Disease

Bibliographic Details
Main Authors:	Zoltán Prohászka, Nicolas S. Merle
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Immunology
Subjects:	COVID-19 SARS – CoV – 2 complement system thromboinflammation kinin-kallikrein system
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.960809/full

Similar Items

Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19
by: Caroline P. Martens, et al.
Published: (2022-09-01)

The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
by: Miklós Lipcsey, et al.
Published: (2021-02-01)

SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems
by: Anne G. Savitt, et al.
Published: (2021-11-01)

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System
by: Pascal Urwyler, et al.
Published: (2020-08-01)

SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy
by: Mina K. Chung, et al.
Published: (2020-08-01)

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection
by: György Sinkovits, et al.
Published: (2021-03-01)

Angiotensin converting enzyme 2 (ACE2) - the major receptor for SARS-CoV-2 virus
by: Sonia Frankowska, et al.
Published: (2021-04-01)

SARS-CoV-2: One Year in the Pandemic. What Have We Learned, the New Vaccine Era and the Threat of SARS-CoV-2 Variants
by: Filippo Scialo, et al.
Published: (2021-05-01)

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)
by: Pascal Urwyler, et al.
Published: (2021-01-01)

Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19
by: Ellinor I. Peerschke, et al.
Published: (2021-08-01)

Chronic Overexpression of Bradykinin in Kidney Causes Polyuria and Cardiac Hypertrophy
by: Carlos C. Barros, et al.
Published: (2018-12-01)

Interrelation among exercise training, cardiac hypertrophy, and tissue kallikrein-kinin system in athlete and non-athlete women
by: Behnam Heidari, et al.
Published: (2022-09-01)

Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trial
by: Pascal Urwyler, et al.
Published: (2023-10-01)

Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
by: Samantha L. Cooper, et al.
Published: (2021-07-01)

Mechanisms involved in hereditary angioedema with normal C1-inhibitor activity
by: Aleksandr Shamanaev, et al.
Published: (2023-05-01)

Early urinary biomarkers of diabetic nephropathy in type 1 diabetes mellitus show involvement of kallikrein-kinin system
by: Lenka Vitova, et al.
Published: (2017-03-01)

Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy
by: Lilian Caroline Gonçalves Oliveira, et al.
Published: (2021-12-01)

COVID-19, Pre-Eclampsia, and Complement System
by: Chiara Agostinis, et al.
Published: (2021-11-01)

Cardioprotective effect of ornitho-kinin in an anesthetized, open-chest chicken model of acute coronary occlusion
by: B.C. Prezoto, et al.
Published: (2009-09-01)

Plasma Kallikrein as a Modulator of Liver Injury/Remodeling
by: Ibrahim A Ahmed, et al.
Published: (2021-09-01)

The Plasma Kallikrein–Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice
by: Bo Wang, et al.
Published: (2018-02-01)

In Vitro Modeling of Bradykinin-Mediated Angioedema States
by: François Marceau, et al.
Published: (2020-08-01)

Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies
by: Rahmeh Othman, et al.
Published: (2021-07-01)

Coagulation Profile of COVID-19 Patients
by: Georgia Kaiafa, et al.
Published: (2022-10-01)

The Effects of the Contact Activation System on Hemorrhage
by: Fabrício Simão, et al.
Published: (2017-07-01)

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
by: Meng Wu, et al.
Published: (2018-08-01)

COVID-19 and Lung Mast Cells: The Kallikrein–Kinin Activation Pathway
by: Seigo Nagashima, et al.
Published: (2022-02-01)

Rationale for targeting complement in COVID‐19
by: Anastasia Polycarpou, et al.
Published: (2020-08-01)

COVID‐19 pneumonia with back pain: Presentation of an acute pulmonary embolism associated with novel coronavirus infection in an outpatient setting
by: Kenyani Davis
Published: (2020-12-01)

Study of changes in proteolytic systems of rats under conditions of experimental chronic prostatitis
by: O. Kashtelyan, et al.
Published: (2022-03-01)

Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19
by: B. Solun, MD, et al.
Published: (2020-09-01)

Molecular biology of the kallikrein-kinin system: from structure to function
by: J.B. Pesquero, et al.
Published: (1998-09-01)

Reminiscences of Ervin G Erdös
by: Igić Rajko
Published: (2019-01-01)

COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant
by: Pinte Larisa, et al.
Published: (2022-06-01)

Kinins and Kinin Receptors in Cardiovascular and Renal Diseases
by: Jean-Pierre Girolami, et al.
Published: (2021-03-01)

Circulating mortalin in blood and activation of the alternative complement pathway as risk indicators in COVID-19 infection
by: Maya Avraham, et al.
Published: (2024-04-01)

Complement Levels at Admission Reflecting Progression to Severe Acute Kidney Injury (AKI) in Coronavirus Disease 2019 (COVID-19): A Multicenter Prospective Cohort Study
by: Brandon M. Henry, et al.
Published: (2022-04-01)

Hemostatic laboratory derangements in COVID-19 with a focus on platelet count
by: Ariunzaya Amgalan, et al.
Published: (2020-08-01)

Ameliorative Effect of Dabigatran on CFA-Induced Rheumatoid Arthritis via Modulating Kallikrein-Kinin System in Rats
by: Mahmoud E. Youssef, et al.
Published: (2022-09-01)

Neuroprotective Effects of Kinin B2 Receptor in Organotypic Hippocampal Cultures of Middle-Aged Mice
by: Mariana Toricelli, et al.
Published: (2019-07-01)